Adaptive Biotechnologies (ADPT) Cash & Equivalents Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) Cash & Equivalents Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -20.26% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 14.02% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 11.37% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 39.74% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -14.97% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 70.63% |
| 10 | Adaptive Biotechnologies | 3.78 Bn | 3.56 Bn | 52.17 Mn | -6.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.40% |
| Dec 31, 2025 | -7.83% |
| Sep 30, 2025 | -36.76% |
| Jun 30, 2025 | -17.34% |
| Mar 31, 2025 | -23.87% |
| Dec 31, 2024 | -29.89% |
| Sep 30, 2024 | -32.24% |
| Jun 30, 2024 | -31.26% |
| Mar 31, 2024 | -25.69% |
| Dec 31, 2023 | -19.22% |
| Sep 30, 2023 | -43.70% |
| Jun 30, 2023 | -33.14% |
| Mar 31, 2023 | -23.66% |
| Dec 31, 2022 | -2.31% |
| Sep 30, 2022 | 42.65% |
| Jun 30, 2022 | 16.39% |
| Dec 31, 2021 | 36.21% |